Is Johnson and Johnson a blue-chip stock? (2024)

Is Johnson and Johnson a blue-chip stock?

Blue chip stocks are the stocks of dependable, profitable companies that have stood the test of time. Investing in high-quality blue chip companies can be a way to strengthen your stock portfolio. Apple, Berkshire Hathaway, Coca-Cola, Johnson & Johnson, and American Express stand out as top blue chip stocks.

Is JNJ a blue chip stock?

Johnson & Johnson (NYSE: JNJ): With a commitment to medical innovation and a diverse product pipeline, JNJ stands as a blue-chip stock offering long-term growth, stability, and a healthy dividend yield.

Is JNJ stock worth buying?

Lately, J&J stock has been trading for 14.8x the midpoint of management's adjusted earnings expectation for 2024. This price is more than fair for a company that grew adjusted earnings by a double-digit percentage last year and could continue reporting gains at a high single-digit percentage in the years ahead.

Which bluechip stock is best?

What is considered a blue chip stock?

A blue chip stock is a company that typically has a large market cap, a sterling reputation, excellent financials, and many years of success in the business world. A blue-chip index seeks to track the performance of financially stable, well-established companies that provide investors with consistent returns.

Is Johnson and Johnson a safe stock?

Key Points. Johnson & Johnson is one of the top healthcare companies in the world, with a market cap of nearly $400 billion. The company, however, faces an uncertain future because of its unsettled talc lawsuits. The litigation could threaten its dividend and long-term growth prospects.

Why is Johnson and Johnson a blue chip stock?

Johnson & Johnson: Still the rock-solid dividend stock you can count on. This has always been a stock that investors could buy and hold and not lose a wink of sleep over. The company's diversification and tremendous presence in healthcare made it a genuine blue-chip stock.

Is JNJ a good long term stock?

Valuation metrics show that Johnson & Johnson may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of JNJ, demonstrate its potential to outperform the market. It currently has a Growth Score of D.

What is the long term outlook for JNJ?

In December, the company announced its long-term guidance, which projected an annual growth rate between 5% and 7% from 2025 through to 2030.

Which stock is better Pfizer or Johnson and Johnson?

PFE's forward EV/Sales multiple of 2.94 is lower than JNJ's 4.35. PFE's forward EV/EBITDA multiple of 8.78x is lower than JNJ's 12.07x. PFE's trailing-12-month levered FCF margin of 8.29% is lower than JNJ's 23.23%. In addition, PFE's trailing-12-month asset turnover ratio of 0.33x is lower than JNJ's 0.48x.

Should you hold blue chip stocks?

Blue-chip stocks typically have solid balance sheets, steady cash flows, proven business models, and a history of increasing dividends. For that reason, investors generally consider blue-chip stocks to be among the most secure stock investments because of their track records and performance history.

Should I keep blue chip stocks?

Blue chip stocks are usually less risky and thus considered safer than other stock-based investment options. That's because one of the major determining factors of a blue chip stock is that it must be a well-capitalized company, meaning it should have the financial fortitude to endure an inevitable economic downturn.

Which is the best stock to buy in 2024?

What stock will make me rich in 2024?

What are the best American stocks to buy?

What are the best stocks for long term investment?

Who owns the most Johnson and Johnson stock?

According to the latest TipRanks data, approximately 61.13% of Johnson & Johnson (JNJ) stock is held by retail investors. Vanguard owns the most shares of Johnson & Johnson (JNJ).

Who owns the most shares of JNJ?

Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, Geode Capital Management, Llc, Morgan Stanley, State Farm Mutual Automobile Insurance Co, Spdr S&p 500 Etf Trust, and ...

What is the JNJ controversy?

Johnson & Johnson faces allegations it failed to properly warn consumers about potential health risks associated with its talc-based baby powder, including alleged cancer risks.

Why do people invest in Johnson and Johnson?

Key Points. Johnson & Johnson has a massive footprint in healthcare, even after spinning off its consumer products segment. Fantastic financials give the company lots of flexibility to acquire growing assets strategically. Shares are attractive at the current price, and a safer stock is hard to find.

Is Apple a blue chip stock?

Number of Hedge Fund Investors: 134

Apple Inc (NASDAQ:AAPL) is undoubtedly one of the best blue chip stocks to buy and hold according to hedge funds.

What is the difference between a regular stock and a blue chip stock?

Income stocks provide regular income by distributing a company's profits, or excess cash, through dividends that are higher than the market average. Blue-chip stocks are shares of well-established companies with a large market capitalization.

What are the safest stocks to buy long-term?

What are analysts saying about JNJ stock?

Based on analysts offering 12 month price targets for JNJ in the last 3 months. The average price target is $174.8 with a high estimate of $215 and a low estimate of $155.

What will happen to JNJ shares?

What does the J&J split mean for shareholders? If you currently own shares of Johnson & Johnson, when the company splits, you will own shares of both Johnson & Johnson – which will be the new pharmaceutical/medical device business – as well as shares of Kenvue, the new consumer health business.